Iceland - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Iceland Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry jumped by 43.9% year on year. With $1,474,601.4 Million PPP in 2019, the country was ranked number 32 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Iceland is overtaken by Slovakia, which was number 31 at $4,291,243.82 Million PPP and is followed by Estonia at $1,275,641.95 Million PPP. United States ranked the highest with $70,565,318,932.39 Million PPP in 2019, a growth of 3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania witnessed the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 1,474,601.40 |
| 2018 | 1,461,359.78 |
| 2017 | 1,093,916.49 |
| 2016 | 1,390,990.45 |
| 2015 | 990,581.42 |
How does Iceland rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 31 |
#31
Slovakia
|
4,291,243.82 | 2019 | -17.4 % | -13.2 % | View data | |
| 32 |
#32
Iceland
|
1,474,601.40 | 2019 | +0.9 % | +43.9 % | View data | |
| 33 |
#33
Estonia
|
1,275,641.95 | 2019 | -0.9 % | -9.8 % | View data | |